Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03646032 · ClinicalTrials.gov registry record · NA
Sexually Active Adolescent Focused Education
A NA study of Health Risk Behaviors, sponsored by Benten Technologies.
- Completed
- Registry status
- NA
- Development phase
- 178
- Enrollment target
- 2
- Study locations
NCT03646032 is a NA study of Health Risk Behaviors that has completed, run by Benten Technologies. The registered enrollment target is 178 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03646032, a NA study of Health Risk Behaviors, has completed, sponsored by Benten Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
- 2
- Study locations
Study Summary
SAAFE will be pilot tested in 2 geographically distinct areas (Washington, DC and Deep South) with 100 participants from each site to 1) primarily assess the efficacy of improved self-efficacy, knowledge about HIV/STIs and perception of sexual risks by AAAs, and (2) secondarily detect intention to be tested for STIs and to change sexual risk behavior (i.e., use a condom).
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL SAAFE
Study Locations (2)
Alabama
- The University of Alabama at Birmingham - Birmingham
District of Columbia
- Medstar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2019-05-08 |
| Est. Completion | 2019-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03646032
The ClinicalTrials.gov registry entry for NCT03646032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Benten Technologies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Health Risk Behaviors appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT03646032 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03646032 about?
NCT03646032 is a clinical study titled "Sexually Active Adolescent Focused Education". SAAFE will be pilot tested in 2 geographically distinct areas (Washington, DC and Deep South) with 100 participants from each site to 1) primarily assess the efficacy of improved self-efficacy, knowledge about HIV/STIs and perception of sexual risks by AAAs, and (2) secondarily detect intention to b...
What is the current status of trial NCT03646032?
This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2019-05-08. Estimated completion is 2019-07-15.
What conditions does trial NCT03646032 study?
This clinical trial studies the following conditions: Health Risk Behaviors.
What interventions are being tested in trial NCT03646032?
The interventions under investigation include: Control (BEHAVIORAL), SAAFE (BEHAVIORAL).
Who is sponsoring clinical trial NCT03646032?
This trial is sponsored by Benten Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03646032 being conducted?
This trial has 2 study locations across Alabama, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Risk Behaviors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.